Benzinga | Mar 2, 2021 11:11AM EST

Oppenheimer Initiates Coverage On Pharvaris with Outperform Rating, Announces Price Target of $48

Oppenheimer analyst Justin Kim initiates coverage on Pharvaris (NASDAQ:PHVS) with a Outperform rating and announces Price Target of $48.